Notch Therapeutics, Inc. — Form D

Notch Therapeutics, Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-17. The offering totals $15.5M, of which $15.5M was reported sold. Industry: Other.

Offering

Filed: 2024-06-17
Form: D
Accession: 0001847926-24-000001
Industry: Other
Exemptions: 06b
Total offering: $15.5M
Amount sold: $15.5M
Investors: 16
Date of first sale: 2024-05-17
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-516124

Issuer

Name: Notch Therapeutics, Inc.
CIK: 0001847926
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 300-2233 Columbia Street, VANCOUVER, A1, V5Y 0M6
Phone: 778-654-8588

Officers, directors & promoters (11)

Name	Role	Location
STEPHEN R BIGGAR	Director	HAMILTON, D0
Heather R Lee	Director	Vancouver, A1
David Main	Director	Vancouver, A1
Ulrik R Nielsen	Director	Vancouver, A1
Janet R Rossant	Director	Vancouver, A1
Caroline R Stout	Director	Vancouver, A1
Kamran R Alam	Executive Officer	Vancouver, A1
Chris R Bond	Executive Officer	Vancouver, A1
Bernard R Lam	Executive Officer	Vancouver, A1
David Main	Executive Officer	Vancouver, A1
Emily R Titus	Executive Officer	Vancouver, A1

More